Navigation Links
China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results
Date:3/23/2009

XI'AN, China, March 23 /PRNewswire-Asia-FirstCall/ -- China Bio Energy Holdings Group (OTC Bulletin Board: CBEH), a leading manufacturer and distributor of bio-diesel and distributor of petroleum-related products including gasoline, diesel, and heavy oil in China, today announced its financial results for the fourth quarter and fiscal year 2008.



    SUMMARY FINANCIALS

    Fourth Quarter 2008 Results
                                     Q4 2008        Q4 2007        CHANGE
    -Sales                        $59.1 million  $22.3 million     +165.0 %
    Gross Profit                   $7.5 million   $2.7 million     +176.0 %
    GAAP Net Income (Loss)        ($3.3 million)  $2.1 million     -259.3 %
    Adjusted Net Income*           $6.5 million   $2.1 million     +209.5 %
    GAAP EPS                          ($0.13)        ($0.05)          -60 %
    Adjusted EPS (Fully Diluted)*      $0.17         ($0.05)         +340 %


    Fiscal Year 2008 Results
                                     FY 2008        FY 2007        CHANGE
    -Sales                       $216.5 million  $87.1 million     +149.0 %
    Gross Profit                  $30.6 million  $10.1 million     +203.5 %
    GAAP Net Income               $18.7 million   $8.6 million     +118.0 %
    Adjusted Net Income*          $28.6 million   $8.6 million     +232.7 %
    GAAP EPS                           $0.54          $0.21        +157.1 %
    Adjusted EPS (Fully Diluted)*      $0.84          $0.21        +300.0 %

    * Net Income and EPS in the Q4 2008 and Fiscal Year 2008 are non-GAAP
      calculations and do not include $9.8 million of non-cash, stock-based
      compensation charges related to the ''Make Good'' provision of an
      October 2008 financing agreement.

For more information about the non-GAAP financial measures contained in this press release, please see ''About Non-GAAP Financial Measures" below.

Fourth Quarter 2008 Financial Results

Sales - Sales for the fourth quarter of 2008 were $59.1 million compared to $22.3 million in the fourth quarter of 2007, an increase of 165%. The increase was mainly due to market demand in finished oil, strong growth in bio-diesel production and sales generated by the four recently leased gas stations. China Bio Energy also reports revenue in its three business segments, Distribution of Finished Oil, Bio-Diesel Production, and Retail Gas Stations:



    Fourth Quarter 2008 Revenue Breakdown
                                      Q4 2008         Q4 2007         CHANGE
    Distribution of Finished Oil   $36.7 million   $18.1 million       +103 %
    % of Sales                         62.3%           81.1%
    Bio-Diesel Production          $14.9 million    $4.2 million       +255 %
    % of Sales                         25.3%           18.9%
    Retail Gas Stations             $7.5 million        N/A             N/A
    % of Sales                         12.4%            N/A
    Total Sales                    $59.1 million   $22.3 million       +166 %

''We are very pleased with our progress during the fourth quarter,'' stated Mr. Gao Xincheng, Chief Executive Officer of China Bio Energy Holdings Group. ''The Company's bio-diesel sales increased 255% for the fourth quarter of 2008, compared to the fourth quarter of 2007. Despite declining oil prices in China and worldwide, we feel there are several fundamental factors that will continue to provide incremental and robust top-line growth for our Company. These include China's continuing demand for energy to accommodate future economic growth which will benefit from the stimulus plan and further domestic expansion, an increase of consumer automobiles in China, a shortage of domestic oil resources and dependence on foreign sources, in addition to government initiatives to increase the utilization rate for alternative fuel while decreasing pollution emissions.''

Cost of Sales - Cost of sales for the fourth quarter of 2008 was $51.5 million compared to $19.6 million in 2007, an increase of 162.8%. The increase was due to the rise in production and sales activities. Cost of sales as a percentage of sales was approximately 87.1% for the fourth quarter of 2008 and 87.8% for same period in 2007. The decrease was due to lower production costs resulting from a decrease in the cost of feedstock used to produce bio-diesel. Overall average unit costs of feedstock, which is comprised of used cooking oil and non-edible seeds, amounted to $463.2 per ton in the fourth quarter 2008, representing a decrease of 12.8% from $529.9 per ton in the fourth quarter of 2007.

Gross Profit and Gross Margin - Gross profit was $7.5 million for the fourth quarter of 2008 compared to $2.7 million for the same period in 2007, an increase of 177.8% and representing gross margins of approximately 13% and 12%, respectively. The increase in gross margin is primarily due to the rise in market demand for finished oil products and bio-diesel, and a reduction in bio-diesel supply costs. During the fourth quarter of 2008, the gross profit margin for bio-diesel production and sales was approximately 27.5% while gross profit margin for distribution of finished oil products, such as gasoline and diesel oil, was approximately 8.3%. The retail gas stations during this same period had a gross margin of 11.2%.

Operating Expenses - Selling, general and administrative expenses for the fourth quarter of 2008 were approximately $1.0 million compared to $0.89 million for the same period in 2007, an increase of 16.9%. Total operating expenses as a percentage of sales for the fourth quarter of 2008 and 2007 were 1.7% and 4.0%, respectively.

Net Income - For the quarter ended December 31, 2008, the Company reported a net loss of $3.3 million, or a loss of $0.13 per diluted share compared to net income of $2.1 million, and a loss of $.05 per diluted share, in the fourth quarter of 2007. Diluted weighted average shares outstanding were 32.9 million and 25.1 million for the fourth quarter of 2008 and 2007, respectively. Adjusted net income for the fourth quarter of 2008, excluding the $9.8 million charge in stock-based compensation expenses related to the ''Make Good'' provision of an October 2008 financing agreement, was $6.5 million or $0.17 per diluted share, which represented a 209.5% increase, compared to the same period in 2007.

Fiscal Year 2008 Financial Results

Sales - Sales for 2008 were $216.5 million, an increase of 149% compared to $87.1 million in 2007. The increase was mainly due to strong growth in bio-diesel sales with production increasing to 58,701 tons in 2008 from 5,836 tons in 2007, solid increases in the Company's distribution segment to existing and new customers, in addition to sales generated by the four newly leased gas stations, which were not managed during 2007.



    Fiscal Year 2008 Revenue Breakdown
                                       FY 2008         FY 2007        CHANGE
    Distribution of Finished Oil   $143.4 million   $82.9 million     +73.0 %
    % of Sales                           66.3%          95.2%
    Bio-Diesel Production           $50.1 million    $4.2 million   +1092.8 %
    % of Sales                           23.1%           4.8%
    Retail Gas Stations             $23.0 million        N/A            N/A
    % of Sales                           10.6%           N/A
    Total Sales                    $216.5 million   $87.1 million      +149 %

Cost of Sales - Cost of sales for 2008 was $185.9 million compared to $77.0 million in 2007, an increase of $108.9 million, or 141%. The increase was due to the sharp rise in production and sales activities during 2008. Cost of sales as a percentage of sales was approximately 86% for 2008 and 88% for 2007. The decrease was due to lower production costs resulting from proprietary production of bio-diesel that commenced in October 2007 and from a decrease in the cost of feedstock used to produce bio-diesel.

Gross Profit and Gross Margin - Gross profit was $30.6 million for 2008 compared to $10.1 million for 2007, an increase of 203.5% and representing gross margins of approximately 14% and 12%, respectively. The increase in gross margin is primarily due to the rise in market demand for finished oil products and bio-diesel, and a reduction in bio-diesel supply costs. During 2008, the gross profit margin for bio-diesel production and sales was approximately 28.5% while gross profit margin for distribution of finished oil products, such as gasoline and diesel oil, was approximately 10.8%. The retail gas stations during this same period yielded gross margins of 10.9%.

Operating Expenses - Selling, general and administrative expenses for 2008 were approximately $2.0 million compared to $1.69 million for 2007, an increase of $0.31 million or 18.4%, resulting from higher costs and salaries of staff to support the expansion and growth during 2008. There was also an increase in audit, legal, consulting and filing expenses in connection with the Company becoming public in the U.S. in October 2007. Total operating expenses as a percentage of sales for 2008 and 2007 were 0.9% and 1.9%, respectively.

Net Income - GAAP Net income for 2008 was $18.7 million compared to $8.6 million in 2007, an increase of $10.1 million or 118%. Adjusted Net income, excluding the $9.8 million charge of stock-based compensation expenses, was $28.6 million, which represented a 232.7% increase compared with same period in 2007. This increase is attributable to economies of scale combined with rapid growth in revenue especially from bio-diesel sales, and efficiency of operations by the management with emphasis on cost control. Fully diluted GAAP earnings per share were $0.54 compared to $0.21 based on 32.9 million and 25.1 million diluted shares outstanding. Excluding the non-cash charge of stock-based compensation, the Company would have reported fiscal year 2008 fully diluted earnings of $0.84 per share.

Liquidity and Capital Resources

Cash and cash equivalents were $23.1 million on December 31, 2008, which includes $14 million from financing completed in October 2008), compared to $1.4 million on December 31, 2007. The Company had working capital of $67.5 million on December 31, 2008 and a current ratio of 7.3 to 1. Inventories were $22.3 million and the accounts receivable balance was $8.2 million on December 31, 2008, compared to $12.0 and $0.3 million on December 31, 2007, respectively. The annualized days sales outstanding for the fiscal year 2008 were 7 days. Net cash provided by operations was $8.7 million in 2008, compared to $5.1 million used by operations in 2007. The net cash inflow increased during 2008 was primarily due to a large increase in net income, excluding $10.9 million in non-cash charges.

Financial Outlook for 2009

Management expects to report fiscal year 2009 revenues of at least $240.7 million and net income of at least $33.7 million, representing an increase of 11% and 18% compared to 2008 revenue and adjusted net income, respectively. Guidance includes the addition of 50,000 tons of incremental bio-diesel production capacity expected to come online during Q3 2009 and does not include the planned acquisition or lease of additional retail services stations.

Business Outlook for 2009

China Bio Energy's management plans to focus on growing its bio-diesel production, its distribution business, and expanding the footprint of its retail service stations. On the distribution and retail side, the Company benefits from its advantageous location, well-established supplier relationships as well as an extensive distribution network that has valuable railway access to reach remote parts of China that other distribution companies cannot currently reach. The Company plans to strengthen its outreach in certain key distribution areas. It also plans to add another five to seven retail gas stations through acquisition or lease, which will benefit its overall distribution profit margins.

The Company also plans to expand its current bio-diesel production capacity of 100,000 tons to 150,000 tons, either through strategic acquisitions or through a new build-out in 2009. The Company anticipates $15 million in capital expenditures to accomplish this goal. China Bio Energy has secured adequate raw materials to supply 150,000 tons of capacity, and is working towards securing more long-term sources of raw materials.

Management believes the increase in sales volume from these initiatives will not only offset the impact of current decrease in fuel prices but also favorably impact overall profits.

"Our proprietary bio-diesel production capabilities allow us to utilize multiple types of feedstock, which provide better input cost controls while ensuring optimal capacity utilization. We are the only integrated bio-diesel producer in China with a distribution license and are one of only three companies in Shaanxi licensed to distribute both finished and heavy oil, two factors which create significant barriers to entry and strong competitive advantages. Due to our geographic location and long-established supplier relationships we are able to consistently execute on our growth strategies. We will continue to capitalize on our extensive distribution network, which includes valuable railway rights that gives us exclusive access to Yunnan, Sichuan and Guizhou Provinces. We are supported by a vertically integrated distribution platform that covers a geographic population of approximately 640 million people. Couple this with the ability to leverage our own retail fuel stations, we feel we have several competitive advantages over our domestic competitors while operating a business with superior profit margins," Mr. Gao concluded.

Conference Call Information

Management will host an earnings conference call on March 26, 2009 at 8:30am ET. Interested parties may access the call by dialing +1-800-762-8779 from within the United States, or +1-480-248-5081 if calling internationally. The conference ID is 4031258. It is advisable to dial in approximately 5-10 minutes prior to the start of the call. A replay will be available through March 27, 2009 and can be accessed by dialing +1-800-406-7325 (U.S.), +1-303-590-3030 (Int'l), passcode 4031258.

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at http://www.viavid.net or at the following link: http://viavid.net/dce.aspx?sid=00005FF9 . To access the web cast, you will need to have the Windows Media Player on your desktop. For the free download of the Media Player please visit: http://www.microsoft.com/windows/windowsmedia/en/download/default.asp.

About China Bio Energy Holdings Group

CBEH is a distributor of refined oil products including gasoline, diesel, and heavy oil, and a manufacturer and distributor of bio-diesel fuel. CBEH's bio-diesel fuel is made at its 100,000-ton capacity facility in Shaanxi Province. Feedstock consists of naturally growing non-edible seeds and waste oil from restaurants. CBEH's bio-diesel can be used as a complete substitute for petro-diesel or can be blended with petro-diesel. The Company's products are sold via its own distribution network, which includes four fuel depots in Shaanxi Province that have both road and rail access.

Safe Harbor Statement

This press release contains certain statements that may include "forward-looking statements". All statements other than statements of historical fact included herein are "forward-looking statements". These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

About Non-GAAP Financial Measures

To supplement our consolidated financial statements, which statements are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures: non-GAAP net income, and non-GAAP EPS. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non- GAAP financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures that may not be indicative of our ''recurring core business operating results,'' meaning our operating performance excluding not only non-cash charges, such as stock-based compensation, but also discrete cash charges that are infrequent in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to our historical performance and liquidity as well as comparisons to our competitors' operating results. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business.

    For more information, please contact:

    China Bio Energy Holdings Group
     Alex Gong, VP of Capital Market
     Tel:   +86-136-0127-9912
     Email: alexgong08@gmail.com
     Web:  http://www.cbeh.net.cn/

    OR

    HC International, Inc.
     Ted Haberfield, Executive VP
     Tel:   +1-760-755-2716
     Email: thaberfield@hcinternational.net
     Web:  http://www.hcinternational.net



            CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES
                            CONSOLIDATED BALANCE SHEETS

                                                    For The Year Ended
                                              December 31,       December 31,
                                                 2008                2007
    ASSETS

    CURRENT ASSETS
         Cash and cash equivalents           $23,119,028         $1,382,371
         Restricted cash                         919,351            200,000
         Accounts receivable                   8,164,320            288,589
         Other receivables and deposits        3,986,984          4,403,762
         Prepaid expenses                      1,884,102             41,412
         Advance to suppliers                 17,945,487         16,546,506
         Inventories, net                     22,268,903         12,082,962
         Due from related party                       --            593,696

            Total current assets              78,288,175         35,539,298


          Prepaid rents                        6,408,568                 --
          Property and equipment, net          9,997,674          8,166,250

             Total noncurrent assets          16,406,242          8,166,250

    TOTAL ASSETS                             $94,694,417        $43,705,548

    LIABILITIES AND STOCKHOLDERS' EQUITY

    CURRENT LIABILITIES
         Accounts payable                           $ --           $179,617
         Advance from customers                4,580,462            499,908
         Taxes payable                           735,461            125,015
         Other payables                        3,232,088          3,233,552
         Loans payable                         2,247,197          1,438,164

             Total current liabilities        10,795,208          5,476,256

    Loans payable - Non-current                       --             33,655

    TOTAL LIABILITIES                         10,795,208          5,509,911


    STOCKHOLDERS' EQUITY
         Preferred stock,  $.001 par
          value;  authorized shares
          10,000,000; issued and
          outstanding 3,465,753 and
          1,000,000 shares at
          December 31, 2008 and
          2007, respectively                       3,465              1,000
         Common stock,  $.0001 par
          value;  authorized shares
          79,000,000; issued and
          outstanding 27,169,091 and
          25,454,545 shares at
          December 31, 2008 and
          2007, respectively                       2,716              2,545
         Additional paid in capital           44,434,250         19,611,938
         Statutory reserve                     4,920,114          2,051,030
         Accumulated other comprehensive
          income                               5,337,003          2,319,732
         Retained earnings                    29,201,661         14,209,392

             Total stockholders' equity       83,899,209         38,195,637

    TOTAL LIABILITIES AND STOCKHOLDERS'
     EQUITY                                  $94,694,417        $43,705,548



    CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES
    CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME

                                                    For The Year Ended
                                          December 31, 2008  December 31, 2007

    Sales                                     $216,506,969       $87,104,187

    Cost of goods sold                         185,858,502        77,006,690

    Gross profit                                30,648,467        10,097,497

    Selling, general and administrative
     expenses                                    1,997,818         1,686,760

    Income from operations                      28,650,649         8,410,737

    Non-operating income (expenses)
         Interest expenses                        (125,201)         (142,442)
         Subsidy income                            100,792           328,697
         Other expense                             (63,519)          (17,427)
         Stock based compensation - make
          good provision                        (9,838,354)               --

         Total non-operating expenses           (9,926,282)          168,828

    Net income                                  18,724,367         8,579,565

    Other comprehensive item
         Foreign currency translation gain       3,017,271         1,694,926

    Comprehensive Income                       $21,741,638       $10,274,491

    Net Income                                  18,724,367         8,579,565
    Deemed dividend to preferred
     stockholders                                  863,014         3,398,534
    Net income available to common
     stockholders                               17,861,353         5,181,031

    Basic and diluted weighted average
     shares outstanding
    Basic                                       25,889,748        24,238,107
    Diluted                                     32,877,570        25,145,122

    Basic and diluted net earnings per
     share available to common stockholders
    Basic                                            $0.69             $0.21
    Diluted                                          $0.54             $0.21



    CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES
    CONSOLIDATED STATEMENTS OF CASH FLOW

                                                     For The Year Ended
                                               December 31,      December 31,
                                                   2008              2007
    CASH FLOWS FROM OPERATING ACTIVITIES:
      Net income                               $18,724,367        $8,579,565
      Adjustments to reconcile net income
       to net cash provided by
       (used in) operating activities:
      Depreciation                               1,040,924           228,833
      Bad debt expenses                                 --                --
      Stock based compensation - make
       good provision                            9,838,354                --
      Stock based compensation  - stocks
       to employees                                  9,945                --
        (Increase) decrease in current assets:
          Accounts receivable                   (7,731,421)        5,644,946
          Other receivables, deposits and
           prepaid expenses                     (8,466,631)       (4,099,356)
          Advance to suppliers                    (280,790)      (11,484,067)
          Inventories                           (9,223,710)       (4,098,099)
          Due from related party                   623,581          (245,852)
        Increase (decrease) in current
         liabilities:
          Accounts payable                        (187,219)       (1,889,778)
          Advance from customers                 3,982,577            87,896
          Taxes payable                            592,462          (643,780)
          Other payables and accrued expenses     (217,054)        2,811,389

      Net cash provided by (used in)
       operating activities                      8,705,385        (5,108,303)

    CASH FLOWS FROM INVESTING ACTIVITIES:
          Sale of investment                            --                --
          Acquisition of property and
           equipment                            (1,251,231)       (6,809,173)
          Construction in progress                      --                --

      Net cash used in investing activities     (1,251,231)       (6,809,173)

    CASH FLOWS FROM FINANCING ACTIVITIES:
          Restricted cash                         (718,768)          457,811
          Notes payable - trade                         --                --
          Notes payable - related party                 --                --
          Proceeds from short-term loans           719,942           269,531
          Repayment of short term loan                  --        (1,577,744)
          Proceeds from long-term payables              --                --
          Repayment of auto loans long
           term notes payable                      (54,375)           (4,235)
          Proceeds from issuance of
           preferred stock                       9,000,000         9,774,993
          Proceeds from warrants exercised       5,113,635                --
          Capital contribution                          --         3,905,724
          Advance to shareholder                        --                --
          Repayment from shareholder                    --            22,617

      Net cash provided by financing
       activities                               14,060,434        12,848,697

    EFFECT OF EXCHANGE RATE CHANGE ON
     CASH AND CASH EQUIVALENTS                     222,069          (180,293)

    NET INCREASE IN CASH AND CASH
     EQUIVALENTS                                21,736,657           750,928

    CASH AND CASH EQUIVALENTS, BEGINNING
     OF YEAR                                     1,382,371           631,443

    CASH AND CASH EQUIVALENTS, END OF YEAR     $23,119,028        $1,382,371

    Supplemental Cash flow data:
       Income tax paid                                $ --              $ --
       Interest paid                              $125,201          $137,463



    CHINA BIO ENERGY HOLDING GROUP CO., LTD. AND SUBSIDIARIES
    CONSOLIDATED PROFIT AND LOSS STATEMENTS

                                                 For The Three Months Ended
                                               December 31,      December 31,
                                                   2008              2007

    Sales                                       59,057,147        22,269,492
    Cost of goods sold                          51,549,964        19,553,247
    Gross Profit                                 7,507,183         2,716,245
                                                     12.7%             12.2%
    Operating expenses
     Selling expenses                                   --                --
     General and administrative expenses         1,035,373           885,273
    Total operating expenses                     1,035,373           885,273

    Income from operations                       6,471,810         1,830,972
                                                     11.0%              8.2%
    Non-operating income (expense)
     Interest expenses                             (31,714)          (43,594)
     Subsidy income                                116,157           328,697
     Other income (expenses)                       (60,901)          (17,427)
     Stock-based compensation - make good
      provision                                 (9,838,354)               --
     Total Non-operating income (expense)       (9,814,812)          267,676

    Net income                                  (3,343,002)        2,098,648
                                                     -5.7%              9.4%
    Other comprehensive item
     Foreign currency translation gain (loss)     (172,446)        1,189,031

    Comprehensive income                        (3,515,448)        3,287,679
                                                     -6.0%             14.8%

    Net income                                  (3,343,002)        2,098,648
    Deemed dividend to preferred stockholders      863,014         3,398,534
    Net income available to common
     stockholders                               (4,206,016)       (1,299,886)

    Basic and diluted weighted average
     shares outstanding
    Basic                                       25,819,011        24,238,107
    diluted                                     32,817,152        25,145,122

    Basic and diluted net earnings per share
     available to common stockholders
    Basic                                            -0.16             -0.05
    Diluted                                          -0.13             -0.05



    Net Income (GAAP based) vs. Net Income (Non-GAAP Based)

                                                  For The Year Ended
                                                   December 31, 2008

    Net Income (GAAP)                                    18,724,367

    Stock-based Compensation
     -Make Good Provision                                 9,838,354

    Net Income (Non-GAAP)                                28,562,721


'/>"/>
SOURCE China Bio Energy Holdings Group
Copyright©2009 PR Newswire.
All rights reserved


Related biology technology :

1. aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong
2. Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China
3. China-Biotics, Inc. Appoints New Chief Financial Officer
4. China Medical Technologies Senior Management Purchased Company Shares
5. China Bio-Immunity Corporation - Rabies Vaccine Recall
6. China Medicine to Participate in 2009 Natural Products Expo West Trade Show
7. China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets
8. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
9. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
10. China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
11. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Novan, Inc. today announced that Director Robert A. ... of Novan. In addition, Robert Keegan has been appointed ... . --> North Carolina . ... a total of $32.8 million of net proceeds in a private ... originating throughout the Research Triangle area of North Carolina ...
(Date:2/8/2016)... ... 2016 , ... Franz Inc. , an early innovator ... announced the availability of AllegroGraph 6, the leading Semantic Graph Database with certification ... Program (CCPT). AllegroGraph is the first Semantic Graph Database to be certified ...
(Date:2/6/2016)... ... 06, 2016 , ... The Center for Excellence in Education (CEE) will sponsor ... on Wednesday February 10, 2016. This Bite of Science session, hosted by the ... at 1500 Remount Road in Front Royal, VA from 5:00 p.m. to 8:00 p.m. ...
(Date:2/5/2016)... SAN FRANCISCO , February 5, 2016 ... AMBS), a biotechnology company focused on developing products ... it has requested Rare Pediatric Disease Designation (RPDD) from ... retinitis pigmentosa (RP) with MANF. MANF was previously granted ... December 2014. --> Amarantus BioScience Holdings, Inc. ...
Breaking Biology Technology:
(Date:1/21/2016)... January 21, 2016 ... new market research report "Emotion Detection and Recognition Market by ... Tools (Facial Expression, Voice Recognition and Others), Services, ... forecast to 2020", published by MarketsandMarkets, the global ... reach USD 22.65 Billion by 2020, at a ...
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/13/2016)... 13, 2016 --> ... new market report titled - Biometric Sensors Market - Global ... - 2023. According to the report, the global biometric sensors market was ... to reach US$1,625.8 mn by 2023, expanding at a ... of volume, the biometric sensors market is expected to ...
Breaking Biology News(10 mins):